449 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
SNY Sanofi $43.75 $109.14B N/A
Article Searches
The 7 Most Expensive Prescription Drugs in the World https://www.fool.com/investing/2017/04/18/the-7-most-expensive-prescription-drugs-in-the-wor.aspx?source=iedfolrf0000001 Apr 18, 2017 - The costs of these drugs are astronomical -- from $543,000 per year to more than $1 million per year.
Another Williams Takes His Turn Before the Camera, at SNY https://www.nytimes.com/2017/07/20/business/doug-brian-williams-sny.html?partner=rss&emc=rss Jul 21, 2017 - Doug Williams, a sportscaster, acknowledges he is not as well known as his father, Brian, or sister, Allison. “I enjoy being the ‘other one,’” he says.
Drug Shortages Push Up Prices of Similar Drugs https://www.wsj.com/articles/prescription-drug-shortages-help-push-up-prices-of-similar-drugs-1492030801?mod=pls_whats_news_us_business_f Apr 12, 2017 - Prescription-drug supply shortages have hurt U.S. medical care in recent years. According to new research, they’ve also caused another side effect—drug-price increases.
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion) https://www.fool.com/investing/2017/06/30/the-9-best-selling-prescription-drugs-in-2016-each.aspx?source=iedfolrf0000001 Jun 30, 2017 - These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
Alnylam Pharmaceuticals, Inc. Stock Perked Up 14% in June -- Here's Why https://www.fool.com/investing/2017/07/07/alnylam-pharmaceuticals-inc-stock-perked-up-14-in.aspx?source=iedfolrf0000001 Jul 07, 2017 - A new breakthrough designation and insider purchases helped Alnylam stock continue its terrific climb this year.
3 High-Yield Dividend Aristocrat Stocks https://www.fool.com/investing/2017/08/28/3-high-yield-dividend-aristocrat-stocks.aspx?source=iedfolrf0000001 Aug 28, 2017 - These three high-yield dividend stocks may be worth checking out right now.
Here's the Best Dividend Stock in Big Pharma https://www.fool.com/investing/2017/09/03/heres-the-best-dividend-stock-in-big-pharma.aspx?source=iedfolrf0000001 Sep 03, 2017 - There are plenty of good dividend stocks in big pharma, but AbbVie appears to be the best of all.
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain https://www.fool.com/investing/2017/04/17/lilly-and-incytes-loss-is-abbvie-and-regenerons-ga.aspx?source=iedfolrf0000001 Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop? https://www.fool.com/investing/2017/05/22/these-3-biotech-stocks-have-ballooned-in-2017-but.aspx?source=iedfolrf0000001 May 22, 2017 - It's been a pretty good year for biotech, but these three stocks are outperforming their industry peers. Can they keep it up?
3 Healthcare Stocks to Buy With Dividends Yielding More Than 3% https://www.fool.com/investing/2017/08/29/3-healthcare-stocks-to-buy-with-dividends-yielding.aspx?source=iedfolrf0000001 Aug 29, 2017 - Why AbbVie, Pfizer, and Sanofi are three of the top high-yield healthcare stocks to be found.

Pages: 123456...45

Page 1>